Tuesday, September 3, 2019
The case draws together some 2,000 lawsuits and comes as an Oklahoma court on August 26 fined pharmaceutical and medical equipment manufacturer Johnson & Johnson 572 million dollars for involvement in the US opioid painkiller addiction crisis.
- If the two cases succeed, medical liability lawsuits based on public health risks and costs are likely to increase.
- Medical and biotech firms will try to push back against any increases in their liability regarding opioids and other drugs.
- Opioids will still be medically essential, but market demand for them outside hospitals will likely diminish.